Literature DB >> 7251539

A microtechnique for the determination of antibiotics in muscle.

O Cars, S Ogren.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7251539     DOI： 10.1093/jac/8.1.39

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.

Authors:  J M Entenza; J Vouillamoz; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis.

Authors:  A A McColm; D M Ryan
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid.

Authors:  A Strömberg; U Friberg; O Cars
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

4.  Co-amoxiclav levels in bronchial mucosa.

Authors:  D Honeybourne; J M Andrews; R Wise
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

5.  Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.

Authors:  A Tsitsika; A Pefanis; G S Perdikaris; I Donta; P Karayiannakos; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Authors:  C Thauvin; G M Eliopoulos; S Willey; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.

Authors:  D P Nicolau; C D Freeman; C H Nightingale; C J Coe; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.